American Healthcare REIT (NYSE:AHR) Issues Earnings Results

American Healthcare REIT (NYSE:AHR) posted its quarterly earnings results on Thursday. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.47 by ($0.34), FiscalAI reports. The firm had revenue of $650.77 million for the quarter, compared to analysts’ expectations of $667.57 million. American Healthcare REIT had a net margin of 4.23% and a return on equity of 3.52%. The firm’s revenue for the quarter was up 20.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.38 EPS. American Healthcare REIT updated its FY 2026 guidance to 2.030-2.090 EPS.

American Healthcare REIT Trading Down 2.3%

AHR stock opened at $50.52 on Tuesday. American Healthcare REIT has a 12-month low of $33.71 and a 12-month high of $54.67. The business’s 50-day moving average is $49.98 and its 200 day moving average is $48.91. The company has a current ratio of 0.41, a quick ratio of 0.41 and a debt-to-equity ratio of 0.30. The stock has a market cap of $9.50 billion, a price-to-earnings ratio of 87.11, a PEG ratio of 1.89 and a beta of 0.94.

American Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 17th. Investors of record on Tuesday, March 31st were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 2.0%. The ex-dividend date was Tuesday, March 31st. American Healthcare REIT’s payout ratio is presently 172.41%.

Insider Activity at American Healthcare REIT

In other news, EVP Mark E. Foster sold 2,000 shares of American Healthcare REIT stock in a transaction that occurred on Wednesday, March 25th. The stock was sold at an average price of $48.55, for a total value of $97,100.00. Following the sale, the executive vice president directly owned 56,121 shares of the company’s stock, valued at $2,724,674.55. The trade was a 3.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.75% of the stock is owned by insiders.

Institutional Investors Weigh In On American Healthcare REIT

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada raised its position in shares of American Healthcare REIT by 2,984.1% in the fourth quarter. Royal Bank of Canada now owns 6,161,549 shares of the company’s stock valued at $289,962,000 after buying an additional 5,961,767 shares during the last quarter. Balyasny Asset Management L.P. boosted its position in American Healthcare REIT by 354.0% during the fourth quarter. Balyasny Asset Management L.P. now owns 2,153,129 shares of the company’s stock worth $101,326,000 after acquiring an additional 1,678,850 shares during the last quarter. Federated Hermes Inc. boosted its position in American Healthcare REIT by 130.1% during the fourth quarter. Federated Hermes Inc. now owns 2,557,850 shares of the company’s stock worth $120,372,000 after acquiring an additional 1,445,987 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in American Healthcare REIT by 173.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,459,471 shares of the company’s stock valued at $61,311,000 after acquiring an additional 924,834 shares in the last quarter. Finally, Alyeska Investment Group L.P. purchased a new stake in American Healthcare REIT during the 4th quarter valued at about $43,294,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Citigroup reissued a “market outperform” rating on shares of American Healthcare REIT in a research note on Monday, March 2nd. Scotiabank lifted their price target on American Healthcare REIT from $55.00 to $59.00 and gave the company a “sector outperform” rating in a research note on Wednesday, March 11th. The Goldman Sachs Group set a $60.00 price target on American Healthcare REIT in a report on Monday, March 2nd. Weiss Ratings reissued a “hold (c)” rating on shares of American Healthcare REIT in a report on Monday, April 20th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $60.00 price objective on shares of American Healthcare REIT in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, American Healthcare REIT currently has a consensus rating of “Moderate Buy” and an average target price of $55.18.

American Healthcare REIT Company Profile

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.